mb1 vs glp 1 No supplement can rival powerful agonists like 0z€mpic and it’s irresponsible to market it as an alternative and encourage people to come off their lifesaving meds for an unverified supplement. GLP-1-based therapies for diabetes, obesity
Description
Fast, discreet, and always free
Jamie Bennett, a spokesperson for Wegovy and Ozempic maker Novo Nordisk, declined to comment on the concept of deprescription, noting that its drugs are intended for chronic conditions
"I can make anyone lose a ton of weight, but doing it healthfully, that takes a little bit of work." Reach consumer health reporter Ken Alltucker at [email protected] .
GLP-1s are also not appropriate for : Individuals who are underweight or undernourished Those at risk for sarcopenia (muscle loss) People with low muscle mass or nutritional deficiencies Adults over 65 with osteopenia, osteoporosis, or a recent history of fractures In these cases, reduced appetite and unintended weight loss can accelerate muscle and bone loss, making close medical supervision essential
Changes in weight, fat mass, and lean soft tissue were: 33.0%, 53.4%, and 6.9% (case 1)
